NCT05036226 2025-10-06
COAST
Medical University of South Carolina
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT02024009 2024-07-25
SCALOP-2
University of Oxford
Phase 1/2 Completed
NCT01555281 2022-07-07
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
Swiss Cancer Institute
Phase 1/2 Terminated
NCT00589056 2020-04-24
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT01447589 2016-06-23
NelfLung
Oxford University Hospitals NHS Trust
Phase 1/2 Withdrawn
NCT00233948 2015-04-01
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
City of Hope Medical Center
Phase 1/2 Terminated
NCT00704600 2014-12-08
Nelfinavir
Maastricht Radiation Oncology
Phase 1/2 Completed